Creative Medical Technology (OTCMKTS:CELZ) Shares Pass Below 50-Day Moving Average of $0.73

Shares of Creative Medical Technology Holdings, Inc. (OTCMKTS:CELZGet Rating) crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.73 and traded as low as $0.71. Creative Medical Technology shares last traded at $0.74, with a volume of 227,641 shares.

Creative Medical Technology Price Performance

The company’s 50-day simple moving average is $0.73 and its 200 day simple moving average is $1.61.

Institutional Trading of Creative Medical Technology

Large investors have recently added to or reduced their stakes in the business. UBS Group AG bought a new stake in Creative Medical Technology in the first quarter worth approximately $36,000. Citigroup Inc. bought a new stake in Creative Medical Technology in the first quarter worth approximately $47,000. Perkins Capital Management Inc. bought a new stake in Creative Medical Technology in the fourth quarter worth approximately $52,000. XTX Topco Ltd bought a new stake in Creative Medical Technology in the first quarter worth approximately $68,000. Finally, State Street Corp bought a new stake in shares of Creative Medical Technology during the 1st quarter worth $90,000. 13.66% of the stock is owned by institutional investors.

About Creative Medical Technology

(Get Rating)

Creative Medical Technology Holdings, Inc, a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility.

Recommended Stories

Receive News & Ratings for Creative Medical Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creative Medical Technology and related companies with MarketBeat.com's FREE daily email newsletter.